bluebird bio Inc (BLUE)
0.348
+0.05
(+16.82%)
USD |
NASDAQ |
Nov 22, 16:00
0.34
-0.01
(-2.30%)
After-Hours: 20:00
bluebird bio Total Liabilities (Quarterly): 470.84M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 470.84M |
| June 30, 2024 | 492.21M |
| March 31, 2024 | 500.44M |
| December 31, 2023 | 424.62M |
| September 30, 2023 | 391.07M |
| June 30, 2023 | 374.37M |
| March 31, 2023 | 338.00M |
| December 31, 2022 | 435.48M |
| September 30, 2022 | 361.24M |
| June 30, 2022 | 393.48M |
| March 31, 2022 | 227.81M |
| December 31, 2021 | 219.52M |
| September 30, 2021 | 469.12M |
| June 30, 2021 | 469.90M |
| March 31, 2021 | 436.95M |
| December 31, 2020 | 426.20M |
| September 30, 2020 | 422.46M |
| June 30, 2020 | 425.76M |
| March 31, 2020 | 408.67M |
| December 31, 2019 | 442.43M |
| September 30, 2019 | 420.51M |
| June 30, 2019 | 386.97M |
| March 31, 2019 | 366.52M |
| December 31, 2018 | 357.77M |
| Date | Value |
|---|---|
| September 30, 2018 | 351.00M |
| June 30, 2018 | 303.98M |
| March 31, 2018 | 296.61M |
| December 31, 2017 | 277.14M |
| September 30, 2017 | 264.44M |
| June 30, 2017 | 257.11M |
| March 31, 2017 | 257.19M |
| December 31, 2016 | 248.68M |
| September 30, 2016 | 223.75M |
| June 30, 2016 | 182.38M |
| March 31, 2016 | 172.20M |
| December 31, 2015 | 151.84M |
| September 30, 2015 | 128.64M |
| June 30, 2015 | 80.20M |
| March 31, 2015 | 59.32M |
| December 31, 2014 | 65.48M |
| September 30, 2014 | 68.30M |
| June 30, 2014 | 74.87M |
| March 31, 2014 | 65.34M |
| December 31, 2013 | 72.72M |
| September 30, 2013 | 70.56M |
| June 30, 2013 | 73.27M |
| March 31, 2013 | 78.96M |
| December 31, 2012 | 125.07M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
219.52M
Minimum
Dec 2021
500.44M
Maximum
Mar 2024
406.53M
Average
425.19M
Median
Total Liabilities (Quarterly) Benchmarks
| AIM ImmunoTech Inc | 10.68M |
| Perspective Therapeutics Inc | 62.68M |
| Protalix BioTherapeutics Inc | 29.13M |
| Electromed Inc | 7.427M |
| Armata Pharmaceuticals Inc | 149.21M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 465.06M |
| Shareholders Equity (Quarterly) | -5.786M |
| Debt to Equity Ratio | -12.20 |
| Current Ratio | 0.5094 |
| Net Debt Paydown Yield | -14.02% |